CaveoVasc® – Closure Devices in the Pipeline 

CaveoVasc XL
 
  • Covering rapidly increasing market of endovascular procedures
    (e.g. EVAR, aortic valve replacement and mitral valve surgery)

  • These procedures need a big access (16F and more)

  • Modification in shaft size (18 F) and additional channel for application of haemostatic agents, e.g. fibrin glue

 

Advantages
  • Avoiding open surgery in the groin

  • Procedures could be performed completely percutaneous

CaveoVenous
 
  • Covering increasing market of electrophysiolocical procedures such as ablation, percutaneous mitral valve surgery and leadless pacemakers

  • Modification in shaft size and indicator function necessary

 

Advantages
  • Avoiding massive haematoma in the groin

 

CaveoMed GmbH . Vor dem Kreuzberg 17 . 72070 Tübingen . Deutschland . Telefon: +49 (0) 7071 53982-00 . Telefax: +49 (0) 7071 53982-29 . info@caveomed.com       IMPRESSUM